Posted in addiction, addictions, alcoholism, depression, drug makers, drug updates, recovery, suicidality, tagged addiction, alcohol, chantix, cocaine, depression and suicidal behavior, dopamine, eating, obesity, rimonanbant, smoking, Taranabant, weight managment on May 1, 2008 | No Comments »
seeking aid for addictions in prescripton meds: this was an interesting blog by “oasis avanced wellness”, discussing an issue near and dear to my heart…taking meds, often in place of adjusting lifestyle and even when taking it in an effort to work on lifestyle issues…the side effects and direct effects can undermine your best efforts. [...]
Read Full Post »
this isn’t really news…but it was released again today…from the fiercepharma newsletter:
5. Neurontin fails bipolar med review
Comment | Forward to a friend
Review the research on epilepsy meds, and what do you find? Neurontin (gabapentin), is no better than placebo for bipolar disorder, according to the Prescribing for Better Outcomes center at the University of North [...]
Read Full Post »
Posted in FDA, bipolar, drug makers, drug updates, wellbutrinXL, tagged wellbutrin, FDA probe clears generic wellbutrin, generic wellbutrin, teva's generic wellbutrin XL, glaxosmithkline, budeprion XL on April 17, 2008 | No Comments »
from fiercepharma:
5. FDA probe clears generic Wellbutrin
Comment | Forward to a friend
Listen to all those generics makers heaving sighs of relief. The FDA has given the thumbs-up to Teva’s generic Wellbutrin XL, which has been under investigation since early last year. Patients who’d switched from GlaxoSmithKline’s branded form of 300 mg pill to Teva’s Budeprion [...]
Read Full Post »
Posted in FDA, big pharma, consumers' rights, drug makers, drug updates, tagged FDA, drug makers, big pharma, pfizer reuling, vioxx, bayer's baycol, FDA reviewers, approved drugs, drug safety on March 27, 2008 | No Comments »
i don’t think i need to comment about this one! is it any surprise that understaffed FDA approvals that are rushed to meet the deadline are more likely to be unsafe when they reach the public?
from fiercepharma newsletter:
When FDA reviewers cram, do they perform poorly on the test? A new study concludes that yes, when [...]
Read Full Post »
from the wallstreet journal, doctors can get faster notification of updates about drugs…if they sign up for the service. the AMA is one of the groups behind the nonprofit group called the iHealth Alliance which is launching the online service:
Drug Updates Via Email:
Just What Doctor Ordered
By SARAH RUBENSTEIN
March 25, 2008; Page D7
At a time of heightened safety [...]
Read Full Post »
